Microbiome Therapy in Covid-19 Primary Care Support

Summary

This double-blind, randomized, placebo-controlled study aims to investigate whether a throat spray containing probiotic bacteria (i.e. microbiome spray) can reduce the symptoms and complaints of the SARS-CoV-2 virus in patients with mild to moderate symptoms. In addition, the aim is to investigate whether the microbiome spray can prevent transmission of the SARS-CoV-2 virus to household members.

Timeline

Start

2021-02-01

Primary completion

2022-02-01

Completion

2022-02-01

Outcome

Outcome not reported

Stopped: “Based on feedback from our study participants on the taste, spray optimization is necessary”

Drugs

Indications